Post Settlement Funding: Invokana Lawsuit Update
Post Settlement Financing Invokana Lawsuit Update. One of the faster growing pharmaceutical litigations involves the diabetes drug, Invokana. Recent news indicates that settlements are being reached among various plaintiffs over the last few months.
Invokana Injuries
Post Settlement Financing Invokana Lawsuit Update. Invokana was introduced in 2013 and was the first in a new group of diabetes drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors. This medicine worked by impacting some normal kidney functions to increase sugar excretion from the body. For type 2 diabetics, Invokana was heavily marketed to help lower glucose levels and thus control the disease.
However, a variety of injuries and health problems soon began plaguing patients that used Invokana. In 2015 and 2016, the FDA began requiring warnings on the drug, due to increases in diabetic ketoacidosis (buildup of blood acids) and acute kidney injury.
Alerts Due to Invokana Use
Post Settlement Financing Invokana Lawsuit Update. 2016 also saw alerts issued for the higher risk of lower-limb amputations due to Invokana use. Diabetes can often cause poor circulation and nerve damage in the lower extremities of the body. Invokana seemed to add to this problem. Studies showed that the risk of amputation could be double the risk of diabetic patients not on the drug.
Added to that in 2018 was an FDA warning about the increased risk of necrotizing fasciitis, an infection that could lead to serious flesh damage (including potential amputation) and death.
Litigation Commences and Settlement Negotiations Bear Fruit
Post Settlement Financing Invokana Lawsuit Update. Various patients who exhibited such injuries began filing suit, accusing drug maker Janssen Pharmaceuticals of failing to adequately warn about the potential risks of using Invokana. Instead, the medication was continually promoted, even for other purposes such as reducing blood pressure or losing weight.
In late 2016, an MDL was established in the U.S. District Court in New Jersey, under Judge Brian Martinotti. Several hundred cases joined the MDL in short order, and by early 2018, it was reported that over 1,000 claims had been filed. At this point, a schedule for bellwether cases was also selected, with the first trial set to begin in Sept. 2018.
However, by late summer, an order from Judge Martinotti indicated there had been recent success settling some Invokana claims. Plaintiffs were told to notify their medical professionals to preserve evidence and records for their claims.
For Attorneys and Plaintiffs Who Don’t Want to Wait for Payment, Balanced Bridge Has An Option.
Post Settlement Financing Invokana Lawsuit Update. Balanced Bridge specializes in post-settlement advances for both attorneys on their fees and plaintiffs on their pending awards. With some plaintiffs now reaching an agreement to settle their Invokana claims, we are in position to provide a financing option for those who need funds and can’t wait months before finalization and distribution.
We can also provide advances to attorneys on their Invokana fees if they’ve reached agreements for their clients but don’t want to wait until those fees are paid out.
Attorneys and plaintiffs involved in any Invokana settlements can feel free to contact us at 267-457-4540 for more information about our funding process, and to see if you could qualify for an advance against your pending fee or award. We usually can proceed with just a few pieces of paperwork regarding the settlement and the award or attorney fee.
You can also find more details on our website, where you can apply online for funding.
